TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in NRS pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 30 second chair stand test (30CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharyngeal clearance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasmatic BRAF and NRAS mutation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lactate dehydrogenase activity in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in therapist reservations about exposure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Therapist Delivery Behavior
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percent syllables correct
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: R0 surgical resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of recovery 40 questionnaire (QoR-40)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma levels of amyloid biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral spinal fluid levels of amyloid biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measures of social engagement/withdrawal
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rebleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Re-bleed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Mortality at 30 days post-discharge
Endpoint domain: Mortality/survival
Primary endpoint: Colostral Milk melatonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of Patients With a Success Rate Based on RGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With a Minimum 2-grade Improvement in RGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percentage Change From Baseline in Individual Lesion Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurochemical response to HG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting 12-lead ECG evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in microarray gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Virologic Response 24 Weeks After Scheduled Completion of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Virologic Response 24 Weeks After Actual End of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electromyography gait analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients recruited per week
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of adverse events (AEs) occurring per week
Endpoint domain: Adverse events/effects
Primary endpoint: soluble biomarkers of liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Suture loosening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: longterm glomerular filtration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dichotomized Glasgow Outcome Scale (GOS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subjective appetite profiles
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Crohn's disease specific health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in general health profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in utility weights
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: fasting venous plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma glucose 2 h after an oral glucose load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Quality of Life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intervention Appropriateness Measure (IAM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity of dengue calculator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of dengue calculator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first nighttime heartburn-free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants Achieving Asthma Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adolescent Asthma Management Self-efficacy Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Asthma Quality-of-life Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fecal Calprotectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Local Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Live birth rate after reaching 24 week's gestation
Endpoint domain: Mortality/survival
Primary endpoint: Wechsler memory scale, fourth edition (WMS-IV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Thyroid Symptom Questionnaire (TSQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QOL as measured by General Health Questionnaire (GHQ)-12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean change in Bar Staff Skills Utilization Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean change in Bar Environment Prevention Practices Checklist
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Changes in life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in caregiver quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Major toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Distance of six minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with clinically significant changes in 12-lead Electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: nPEP Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of malignant tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: King-Devick test speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ROC diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of intra-vitreal anti-VEGF injections
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of malignant and benign pulmonary nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Suicide behavior
Endpoint domain: Mortality/survival
Primary endpoint: E2 plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PG plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: E3 plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: TMG plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Uroflowmetry application performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of macrophage activation markers sCD163
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Measurement of soluble mannose receptor (sMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total motile sperm count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of patients with positive chemical pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of patients with positive clinical pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: maximum tolerated dose of Temsirolimus and Vinorelbine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response rate based on RECIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Patients enrolled and received LEE011
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Length of time receiving study treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Lattinen Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Removal of Para-cresylsulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Removal of Indoxylsulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of SUV-related tumor characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PI3-kinase activity in muscle tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean visual analog scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma Concentration of MNTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Needing ICU Care/Interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decrease in plasma LDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: half life [t1/2]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Weekly Urine Samples Negative for Opiates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paid Work Hours at Week 12
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Paid Work Hours at Week Baseline
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinical cure of recurrent Clostridium difficile infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reproducibility of MRI directed preoperative APBI treatment method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreas attenuation in HU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age in years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI in kg/m2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: compliance with GIHP recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Standard uptake value (SUV) of 68Ga-DOTANOC in pulmonary TB lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill in Intubating Neonatal Manikin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps Twitch force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Thickness of transversus abdominis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: All-Cause Shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exposure of STK-001 in Cerebrospinal Fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline CD4+ Cell Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Controlled Disease According to IGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C13 breath test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Cigarettes Smoked Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Intraoperative Indocyanine green test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: improved assessment of hyperkinetic facial lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Line crossing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in UHDRS Total Maximal Chorea Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of procedures in which SCT was applied as planned
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adverse events during procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events during hospital admission
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with 50% or more change in Urinary Urgency Incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of full cross section image
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Thromboembolism event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with moderate to severe pain after Cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of diagnostic pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Piriformis muscle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants Who Reported One or More Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Vital Sign Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in 12- Lead Electrocardiogram (ECG) Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 7-day Average Instantaneous Morning Diary Congestion/Obstruction Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Polyp Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Persons Screened Who Are Eligible and Enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comparison of Adverse Events in the Bupropion and Placebo Arms
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to Daily Bupropion and Placebo, as Determined by MEMS Caps Openings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 10 Meter Walk Test Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Inpatient Postoperative Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in infant fecal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean age per month of full oral feeding achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macrosomia or birth weight ≥ 90th percentile for gestational age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal hyperbilirubinemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of TCI device adjustments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Photoplethysmography Light Transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who complete radiation therapy, drug treatment and surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients who are ineligible for surgical resection due to toxicity from SBRT + CCX872-B or SBRT alone
Endpoint domain: Adverse events/effects
Primary endpoint: Overall response rate (complete and partial response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentual atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hyperalgesic extent around surgical incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median Event Free Survival (EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Mevalonate Pathway Synthesis and Target Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13-item (ADAS-Cog-13)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline in the Clinical Dementia Rating Sum of the Boxes (CDR-SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Seated Diastolic Blood Pressure Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful Revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Occurrence of Symptomatic Intracerebral Hemorrhage (sICH)
Endpoint domain: Adverse events/effects
Primary endpoint: Any Other Serious Adverse Device Effects (SADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Pravastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to Maximum Concentration (Tmax) of Pravastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Concentration-Time Curve from Hour 0 to the Last Measurable Concentration (AUC0-t) of Pravastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall Event-free Survival (EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Continuous Complete Remission Since Week 56 Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mayer-Salovey Caruso Emotional Intelligence Test (MSCEIT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of local recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Median Relapse-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Rate of overall vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Total Wound Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Blood Hemoglobin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CSS Total Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Resolution of All Treated Warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants receiving autologous transfusion with a decrease in allogeneic transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: WMH development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in Hamilton Depression Scale (HAM-D) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Major Deviation in Cardioplexol application
Endpoint domain: Adverse events/effects
Primary endpoint: change in white substance bundles volumes for structural connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in synchrony amplitude of slow fluctuations for functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of vascular diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of participants with recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with distant metastasis
Endpoint domain: Mortality/survival
Primary endpoint: Change in 60 minutes mean olive tail moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of interleukin-6 (IL-6) cytokine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: major pathological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes